Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells

Immunology

Volumn 89, Issue 4, 1996, Pages 511-517

  Martinez Lorenzo M J ^a   Alava, M A ^a   Anel, A ^a   Pineiro A ^a   Naval, J ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; LIGAND;

APOPTOSIS; ARTICLE; CELL LINE; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029905761     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-782.x     Document Type: Article

References (34)

1. KRAMMER P.H., DHEIN J., WALCZAK H. et al. (1994) The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 142, 175.
2. NAGATA S. & GOLSTEIN P. (1995) The Fas death factor. Science 267, 1449.
3. DHEIN J., WALCZAK, H., BÄUMLER C., DEBATIN K.M. & KRAMMER P.H. (1995) Autocrine T-cell suicide mediated by APO-1 (Fas/ CD95). Nature 373, 438.
4. BRUNNER T., MOGIL R.J., LAFACE D. et al. (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441.
5. JU S.T., PANKA D.J., CUI H. et al. (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444.
6. VIGNAUX F. & GOLSTEIN P. (1994) Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur J Immunol 24, 923.
7. ALDERSON M.R., TOUGH T.W., DAVIS-SMITH T. et al. (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181, 71.
8. RUSSELL J.H. (1995) Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 7, 382.
9. SINGER G.G. & ABBAS A.K. (1994) The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365.
10. LYNCH D.H., RAMSDELL F. & ALDERSON M.R. (1995) Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16, 569.
11. SUDA T., TAKAHASHI T., GOLSTEIN P. & NAGATA S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169.
12. SUDA T., OKAZAKI T., NAITO Y. et al. (1995) Expression of the Fas ligand in cells of T cell lineage. J Immunol 154, 3806.
13. WATANABE-FUKUNAGA R., BRANNAN C.I., COPELAND N.G., JENKINS N.A. & NAGATA S. (1992) Lymphoproliferation disorder explained by defects in Fas antigen that mediate apoptosis. Nature 356, 314.
14. TAKAHASHI T., TANAKA M., BRANNAN C.I. et al. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969.
15. RUSSELL J.H., RUSH B., WEAVER C. & WANG R. (1993) Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 90, 4409.
16. 2+-independent T cell-mediated cytotoxicity. J Exp Med 177, 195.
17. ANEL A., BUFERNE M., BOYER C., SCHMITT-VERHULST A.M. & GOLSTEIN P. (1994) T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol 24, 2469.
18. VIGNAUX F., VIVIER E., MALISSEN B., DEPRAETERE V., NAGATA S. & GOLSTEIN P. (1995) TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med 181, 781.
19. SUDA T. & NAGATA S. (1994) Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179, 873.
20. TANAKA M., SUDA T., TAKAHASHI T. & NAGATA S. (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14, 1129.
21. KAYAGAKI N., KAWASAKI A., EBATA T. et al. (1995) Metalloproteinase-mediated release of human Fas ligand. J Exp Med 182, 1777.
22. MARIANI S.M., MATIBA B., BÄUMLER C. & KRAMMER P.H. (1995) Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur J Immunol 25, 2303.
23. TANAKA M., SUDA T., HAZE K. et al. (1996) Fas ligand in human serum. Nature Med 2, 317.
24. YONEHARA S., ISHII A. & YONEHARA M. (1989) A cell-killing monoclonal antibody (Anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169, 1747.
25. ANEL A., GAMEN S., ALAVA M.A., SCHMITT-VERHULST A.M., PIÑEIRO A. & NAVAL J. (1996) Role of oxidative damage and ICE-like proteases in Fas-based cytotoxicity exerted by effector T cells. Int Immunol 8, 1173.
26. ALLEY M.C., SCUDIERO D.A., MONKS A. et al. (1988) Sensibility of drug screening with panels of human tumor cell lines using microculture tetrazolium assay. Cancer Res 46, 589.
27. 2+-permeable transmembrane channels. Pore formation causes extensive DNA degradation and cell lysis. J Exp Med 169, 765.
28. DHEIN J., DANIEL P.T., TRAUTH B.C., OEHM A., MÖLLER P. & KRAMMER P.H. (1992) Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 149, 3166.
29. GRIFFITH T.S., BRUNNER T., FLETCHER S.M., GREEN D.R. & FERGUSON T.A. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189.
30. WOODS J.W., DORIAUX M. & FARQUHAR M.G. (1986) Transferrin receptors recycle to cis and middle as well as trans Golgi cisternae in Ig-secreting myeloma cells. J Cell Biol 103, 277.
31. ALAVA M.A., DEBELL K.E., CONTI A., HOFFMAN T. & BONVINI E. (1992) Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/ CD3 complex but not by G-protein stimulation. Association with protein kinase A phosphorylation of phospholipase C-γ1. Biochem J 284, 189.
32. HANE M., LOWIN B., PEITSCH M., BECKER K. & TSCHOPP J. (1995) Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain. FEBS Lett 373, 265.
33. GRAF D., MÜLLER M., KORTHÄUER U., VAN KOOTEN C., WEISE C. & KROCZEK R.A. (1995) A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol 25, 1749.
34. LOWIN B., MATTMAN C., HAHNE M. & TSCHOPP J. (1996) Comparison of Fas (Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes. Int Immunol 8, 57.